TickerFactsScreenerDevelopers

Trevi Therapeutics, Inc. (TRVI) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2018: $7.20M2019: $57.31M2020: $45.00M2021: $36.83M2022: $12.59M2023: $32.40M2024: $34.10M2025: $18.91M$18.91M
2018Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$18.91M-44.5%
2024$34.10M+5.2%
2023$32.40M+157.3%
2022$12.59M-65.8%
2021$36.83M-18.2%
2020$45.00M-21.5%
2019$57.31M+695.8%
2018$7.20M—